Trial · NCT01488448
Results by group18
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 18 of 18
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Length of Stay in the Study-LOS--Intention to Treat Analysis | Hypertonic Saline | 2.1 | Inter-Quartile Range 1.2 to 4.6 | Days | |
| Length of Stay in the Study-LOS--Intention to Treat Analysis | Normal Saline | 2.1 | Inter-Quartile Range 1.2 to 3.8 | Days | |
| Readmission for Bronchiolitis Within 7 Days of Discharge | Nebulized Hypertonic Saline | 4 | participants | ||
| Readmission for Bronchiolitis Within 7 Days of Discharge | Nebulized Normal Saline | 3 | participants | ||
| Clinical Worsening | Hypertonic Saline | 10 | participants | ||
| Clinical Worsening | Normal Saline | 9 | participants | ||
| Total Adverse Events | Hypertonic Saline | 14 | adverse events | ||
| Total Adverse Events | Normal Saline | 12 | adverse events | ||
| LOS in Subgroup of Patients With Testing Positive for Respiratory Syncitial Virus (RSV+) | Hypertonic Saline | 2.2 | Inter-Quartile Range 1.6 to 3.8 | days | |
| LOS in Subgroup of Patients With Testing Positive for Respiratory Syncitial Virus (RSV+) | Normal Saline | 2.0 | Inter-Quartile Range 1.2 to 3.2 | days | |
| LOS in Patients With a History of Previous Wheeze | Hypertonic Saline | 1.7 | Inter-Quartile Range 1.1 to 2.6 | days | |
| LOS in Patients With a History of Previous Wheeze | Normal Saline | 2.0 | Inter-Quartile Range 1.2 to 3.2 | days | |
| LOS Subgroup Analysis of Patients With a History of Prematurity | Hypertonic Saline | 2.9 | Inter-Quartile Range 1.9 to 3.6 | days | |
| LOS Subgroup Analysis of Patients With a History of Prematurity | Normal Saline | 2.2 | Inter-Quartile Range 1.2 to 3.2 | days | |
| LOS Analysis for Patients Whose Study Entry Respiratory Distress Assessment Instrument (RDAI) Was Greater Than or Equal to 4 or Who Had Hypoxia <92% | Hypertonic Saline | 2.1 | Inter-Quartile Range 1.3 to 4.1 | days | |
| LOS Analysis for Patients Whose Study Entry Respiratory Distress Assessment Instrument (RDAI) Was Greater Than or Equal to 4 or Who Had Hypoxia <92% | Normal Saline | 2.1 | Inter-Quartile Range 1.3 to 3.7 | days | |
| Length of Stay in the Study-LOS by Per Protocol Analysis | Hypertonic Saline | 2.0 | Inter-Quartile Range 1.3 to 3.3 | Days | |
| Length of Stay in the Study-LOS by Per Protocol Analysis | Normal Saline | 2.0 | Inter-Quartile Range 1.2 to 3.0 | Days |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01488448/results